The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles
Open accessAbstract
BACKGROUND: Inorganic nanoparticles provide promising tools for biomedical applications including detection, diagnosis and therapy. While surface properties such as charge are expected to play an important role in their in vivo behavior, very little is known how the surface chemistry of nanoparticles influences their pharmacokinetics, tumor uptake, and biodistribution. METHOD/PRINCIPAL FINDINGS: Using a family of structurally homologous nanoparticles we have investigated how pharmacological properties including tumor uptake and biodistribution are influenced by surface charge using neutral (TEGOH), zwitterionic (Tzwit), negative (TCOOH) and positive (TTMA) nanoparticles. Nanoparticles were injected into mice (normal and athymic) either in the tail vein or into the peritoneum. CONCLUSION: Neutral and zwitterionic nanoparticles demonstrated longer circulation time via both i.p. and i.v. administration, whereas negatively and positively charged nanoparticles possessed relatively short half-lives. These pharmacological characteristics were reflected on the tumor uptake and biodistribution of the respective nanoparticles, with enhanced tumor uptake by neutral and zwitterionic nanoparticles via passive targeting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The bio-distribution of intraperitoneally and intravenously administrated nanoparticles is similar (48).”
From Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps (2016) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Synthesis of thiol-derivatised gold nanoparticles in a two-phase Liquid–Liquid system
Brust, M., Walker, M., Bethell, D., Schiffrin, D. J., & Whyman, R. (1994) · Journal of the Chemical Society Chemical Communications · doi:10.1039/c39940000801 · Cited by 6,714
Quantum dot bioconjugates for imaging, labelling and sensing
Medintz, I. L., Uyeda, H. T., Goldman, E. R., & Mattoussi, H. M. (2005) · Nature Materials · doi:10.1038/nmat1390 · Cited by 6,236
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Fang, J. Q., Nakamura, H., & Maeda, H. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,573
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,265
Designing materials for biology and medicine
Langer, R., & Tirrell, D. A. (2004) · Nature · doi:10.1038/nature02388 · Cited by 3,198
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 404
Li, X., Zhen, M., Zhou, C., Deng, R., Yu, T., Wu, Y., Shu, C., Wang, C., & Bai, C. (2019) · ACS Nano · doi:10.1021/acsnano.9b02050 · Cited by 83
Exploring and Analyzing the Systemic Delivery Barriers for Nanoparticles
Wang, L., Quine, S., Frickenstein, A. N., Lee, M., Yang, W., Sheth, V. M., Bourlon, M. D., He, Y., Lyu, S., Garcia‐Contreras, L., et al. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202308446 · Cited by 84
Amino Acid Functionalized Inorganic Nanoparticles as Cutting-Edge Therapeutic and Diagnostic Agents
Chakraborty, A., Boer, J. C., Selomulya, C., & Plebanski, M. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00455 · Cited by 85
Multiplexed Imaging of Nanoparticles in Tissues Using Laser Desorption/Ionization Mass Spectrometry
Yan, B., Kim, S. T., Kim, C. S., Saha, K., Moyano, D. F., Xing, Y., Jiang, Y. Y., Roberts, A. L., Alfonso, F. S., Rotello, V. M., et al. (2013) · Journal of the American Chemical Society · doi:10.1021/ja406553f · Cited by 82
Self-citationLiu, L., Hitchens, T. K., Ye, Q., Wu, Y. L., Barbe, B., Prior, D. E., Li, W. F., Yeh, F.-C. F., Foley, L. M., Bain, D. J., et al. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.01.021 · Cited by 81
Dreaden, E. C., Mwakwari, S. C., Austin, L. A., Kieffer, M. J., Oyelere, A. K., & El‐Sayed, M. A. (2012) · Small · doi:10.1002/smll.201200333 · Cited by 81
Gd(III)-Dithiolane Gold Nanoparticles for T1-Weighted Magnetic Resonance Imaging of the Pancreas
Holbrook, R. J., Rammohan, N., Rotz, M. W., MacRenaris, K. W., Preslar, A. T., & Meade, T. J. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b00599 · Cited by 78
Interaction of Proteins with Polyelectrolytes: Comparison of Theory to Experiment
Xu, X., Angioletti‐Uberti, S., Lu, Y. Q., Dzubiella, J., & Ballauff, M. (2018) · Langmuir · doi:10.1021/acs.langmuir.8b01802 · Cited by 78
Liu, Z., Chen, X., Zhang, X., Gooding, J. J., & Zhou, Y. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600002 · Cited by 77
王, J. 璟. W., Bai, R., Yang, R., Liu, J., Tang, J., Liu, Y., Li, J., Chai, Z., & Chen, C. (2015) · Metallomics · doi:10.1039/c4mt00340c · Cited by 77
Liu, J., Yu, M., Ning, X., Zhou, C., Yang, S., & Zheng, J. (2013) · Angewandte Chemie · doi:10.1002/ange.201304465 · Cited by 77
Liu, J., Wu, Y., Fu, C., Li, B., Li, L., Zhang, R., Xu, T., & Xu, Z. P. (2020) · Small · doi:10.1002/smll.202002115 · Cited by 76
Liu, L., Ye, Q., Lu, M., Lo, Y.-C., Hsu, Y., Wei, M.-C., Chen, Y.-H., Lo, S., Wang, S.-J., Bain, D. J., et al. (2015) · Scientific Reports · doi:10.1038/srep10881 · Cited by 78
Pawar, V. K., Singh, Y., Sharma, K., Shrivastav, A., Sharma, A., Singh, A., Meher, J. G., Singh, P. K., Raval, K., Kumar, A., et al. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.09.059 · Cited by 78
Huang, S.-J., Wang, T.-H., Chou, Y.-H., Wang, H., Hsu, T., Yow, J.-L., Tzang, B., & Chiang, W. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.04.209 · Cited by 75
La Barbera, L., Mauri, E., D’Amelio, M., & Gori, M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.939855 · Cited by 74
Promising effects of nanomedicine in cancer drug delivery
Wakaskar, R. R. (2017) · Journal of drug targeting · doi:10.1080/1061186x.2017.1377207 · Cited by 74
Targeting Therapeutics to the Glomerulus With Nanoparticles
Zuckerman, J. E., & Davis, M. E. (2013) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2013.06.003 · Cited by 74
Strategies for improving drug delivery: nanocarriers and microenvironmental priming
Khalid, A., Persano, S., Shen, H., Zhao, Y., Blanco, E., Mauro Ferrari, B., & Wolfram, J. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1243527 · Cited by 77
Nanoscale Strategies: Treatment for Peripheral Vascular Disease and Critical Limb Ischemia
Tu, C., Das, S., Baker, A. B., Zoldan, J., & Suggs, L. J. (2015) · ACS Nano · doi:10.1021/nn507269g · Cited by 72
Guerrero-Beltrán, C. E., Bernal‐Ramírez, J., Lozano, O., Oropeza‐Almazán, Y., Castillo, E. C., Garza, J. R., Garcı́a, N., Vela, J., García‐García, A., Ortega, E., et al. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00564.2016 · Cited by 72
Guével, X. L., Henry, M., Motto‐Ros, V., Longo, E., Montañez, M. I., Pelascini, F., Rochefoucauld, O. D. L., Zeitoun, P., Coll, J., Josserand, V., et al. (2018) · Nanoscale · doi:10.1039/c8nr05299a · Cited by 70
Piao, J., Gao, F., Li, Y., Yu, L., Liu, D., Tan, Z., Xiong, Y., Yang, L., & You, Y. (2017) · Nano Research · doi:10.1007/s12274-017-1736-7 · Cited by 69
Liu, X., Jin, Q., Ji, Y. C., & Ji, J. (2011) · Journal of Materials Chemistry · doi:10.1039/c1jm14178c · Cited by 69
On the advancement of polymeric bicontinuous nanospheres toward biomedical applications
Allen, S. D., Bobbala, S. K. R., Karabin, N. B., & Scott, E. A. (2018) · Nanoscale Horizons · doi:10.1039/c8nh00300a · Cited by 70
A Review on the Biodistribution, Pharmacokinetics and Toxicity of Bismuth-Based Nanomaterials
Badrigilan, S., Heydarpanahi, F., Choupani, J., Jaymand, M., Samadian, H., Hoseini‐Ghahfarokhi, M., Webster, T. J., & Tayebi, L. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s250001 · Cited by 69
Probing the biological obstacles of nanomedicine with gold nanoparticles
Li, B., & Lane, L. A. (2018) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1542 · Cited by 68
In situ cellular hitchhiking of nanoparticles for drug delivery
Udofa, E., & Zhao, Z. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115143 · Cited by 67
Ghimire, C., Wang, H., Li, H., Vieweger, M., Xu, C., & Guo, P. (2020) · ACS Nano · doi:10.1021/acsnano.0c04863 · Cited by 66
Lipid-dendrimer hybrid nanosystem as a novel delivery system for paclitaxel to treat ovarian cancer
Liu, Y., Ng, Y., Toh, M. R., & Chiu, G. N. C. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.11.004 · Cited by 63
Metal nanoparticles in cancer: from synthesis and metabolism to cellular interactions
Tuli, H. S., Joshi, R., Kaur, G., Garg, V. K., Sak, K., Varol, M., Kaur, J., Alharbi, S. A., Alahmadi, T. A., Aggarwal, D., et al. (2022) · Journal of nanostructure in chemistry · doi:10.1007/s40097-022-00504-2 · Cited by 63
Adjei, I. M., Sharma, B., Peetla, C., & Labhasetwar, V. D. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.04.019 · Cited by 62
Jeon, M., Kim, G., Lee, W., Baek, S., Jung, H. N., & Im, H. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01010-3 · Cited by 61
Serum Protein Adsorption and Excretion Pathways of Metal Nanoparticles
Vinluan, R. D., & Zheng, J. (2015) · Nanomedicine · doi:10.2217/nnm.15.97 · Cited by 60
Moyano, D. F., Liu, Y., Ayaz, F., Hou, S., Puangploy, P., Duncan, B., Osborne, B. A., & Rotello, V. M. (2016) · Chem · doi:10.1016/j.chempr.2016.07.007 · Cited by 59
Self-citationZhang, F., Correia, A., Mäkilä, E. M., Li, W., Salonen, J., Hirvonen, J. J., Zhang, H., & Santos, H. A. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b02196 · Cited by 59
Li, L., Wang, H., Ye, J., Chen, Y., Wang, R., Jin, D., & Liu, Y. (2022) · Molecules · doi:10.3390/molecules27144408 · Cited by 58
Kumbhar, P. R., Kumar, P., Lasure, A., Ravichandiran, V., & Mandal, D. (2023) · Discover Nano · doi:10.1186/s11671-023-03913-6 · Cited by 60
Size-dependent neutralizing activity of gold nanoparticle-based subunit vaccine against dengue virus
Quach, H. Q., Ang, S. K., Chu, J. J. H., & Kah, J. C. Y. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.08.011 · Cited by 58
Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy
Raut, S., Mooberry, L. K., Sabnis, N. A., Garud, A., Dossou, A. S., & Lacko, A. G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01154 · Cited by 58
Su, Y., Hu, Y., Wang, Y., Xu, X., Yuan, Y., Li, Y., Wang, Z., Chen, K., Zhang, F., Ding, X., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.05.046 · Cited by 57
Asadi, S., Bianchi, L., Landro, M. D., Korganbayev, S., Schena, E., & Saccomandi, P. (2020) · Journal of Biophotonics · doi:10.1002/jbio.202000161 · Cited by 57
Tan, H., Huang, Y., Xu, J., Chen, B., Zhang, P., Ye, Z., Liang, S., Xiao, L., & Liu, Z. (2017) · Theranostics · doi:10.7150/thno.19780 · Cited by 54
Kapadia, C. H., Ioele, S. A., & Day, E. S. (2019) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36840 · Cited by 54
Hyperbranched copolymer micelles as delivery vehicles of doxorubicin in breast cancer cells
Zeng, X., Zhang, Y., Wu, Z., Lundberg, P., Malkoch, M., & Nyström, A. M. (2011) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.25027 · Cited by 53
Jin, R., Liu, Z., Bai, Y., Zhou, Y., & Chen, X. (2018) · ACS Omega · doi:10.1021/acsomega.8b00427 · Cited by 53
Ghosh, S., Lalani, R., Patel, V., Bardoliwala, D., Maiti, K., Banerjee, S., Bhowmick, S., & Misra, A. R. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.01.011 · Cited by 53
Lapatinib nano-delivery systems: a promising future for breast cancer treatment
Bonde, G. V., Yadav, S. K., Chauhan, S., Mittal, P., Ajmal, G., Thokala, S., & Mishra, B. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1449832 · Cited by 50
Fathy, M. M., Fahmy, H. M., Balah, A. M. M., Mohamed, F. F., & Elshemey, W. M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116787 · Cited by 50
From Nanoparticles to Cancer Nanomedicine: Old Problems with New Solutions
Chiang, C., Cheng, M., & Lin, C.-H. (2021) · Nanomaterials · doi:10.3390/nano11071727 · Cited by 49
Adjuvant Novel Nanocarrier-Based Targeted Therapy for Lung Cancer
Sarma, K., Akhter, M. H., Ahmad, I. S., Afzal, O., Altamimi, A. S. A., Alossaimi, M. A., Jaremko, M., Emwas, A.-H. M., & Gautam, P. (2024) · Molecules · doi:10.3390/molecules29051076 · Cited by 47
Nanoparticulate Drug-Delivery Systems for Fighting Microbial Biofilms: From Bench to Bedside
Pîrcălăbioru, G. G., & Chifiriuc, M. C. (2020) · Future Microbiology · doi:10.2217/fmb-2019-0251 · Cited by 47
Differentiation of Cancer Stem Cells through Nanoparticle Surface Engineering
Geng, Y., Amante, J. J., Goel, H. L., Zhang, X., Walker, M. R., Luther, D. C., Mercurio, A. M., & Rotello, V. M. (2020) · ACS Nano · doi:10.1021/acsnano.0c05589 · Cited by 46
Self-citationJiang, C., Wang, X., Teng, B., Wang, Z., Li, F., Zhao, Y., Guo, Y., & Zeng, Q. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c02074 · Cited by 46
Engineering Intelligent Nanosystems for Enhanced Medical Imaging
van Moolenbroek, G. T., Patiño, T., Llop, J., & Sánchez, S. (2020) · Advanced Intelligent Systems · doi:10.1002/aisy.202000087 · Cited by 46
Interfacing Nanomaterials with Biology through Ligand Engineering
Gupta, A., Ndugire, W., Hirschbiegel, C., Grigely, L., & Rotello, V. M. (2023) · Accounts of Chemical Research · doi:10.1021/acs.accounts.3c00255 · Cited by 45
Self-citationDeferoxamine and Curcumin Loaded Nanocarriers Protect Against Rotenone-Induced Neurotoxicity
Mursaleen, L., Somavarapu, S., & Zariwala, M. G. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-191754 · Cited by 44
Recent progress on mitochondrial targeted cancer therapy based on inorganic nanomaterials
Xu, Z., Chen, X., Sun, Z., Li, C., & Jiang, B. (2019) · Materials Today Chemistry · doi:10.1016/j.mtchem.2019.02.004 · Cited by 43
Vijayaraghavalu, S., Gao, Y., Rahman, M. T., Rozic, R., Sharifi, N., Midura, R. J., & Labhasetwar, V. D. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119558 · Cited by 43
Bioorthogonal nanozymes for breast cancer imaging and therapy
Zhang, X., Liu, Y., Doungchawee, J., Castellanos-García, L. J., Sikora, K. N., Jeon, T., Goswami, R., Fedeli, S., Gupta, A., Huang, R., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.03.032 · Cited by 42
Self-citationAlzheimer’s Disease Targeted Nano-Based Drug Delivery Systems
Altinoglu, G., & Adalı, T. (2019) · Current Drug Targets · doi:10.2174/1389450120666191118123151 · Cited by 41
Interventional Nanotheranostics of Pancreatic Ductal Adenocarcinoma
Li, J., Liu, F., Gupta, S. K., & Li, C. (2016) · Theranostics · doi:10.7150/thno.15122 · Cited by 42
Determination of the Intracellular Stability of Gold Nanoparticle Monolayers Using Mass Spectrometry
Zhu, Z., Tang, R., Yeh, Y., Miranda, O. R., Rotello, V. M., & Vachet, R. W. (2012) · Analytical Chemistry · doi:10.1021/ac203408v · Cited by 41
Self-citationElci, S. G., Yan, B., Kim, S. T., Saha, K., Jiang, Y. Y., Klemmer, G. A., Moyano, D. F., Tonga, G. Y., Rotello, V. M., & Vachet, R. W. (2016) · The Analyst · doi:10.1039/c6an00123h · Cited by 41
Self-citationAdvances in nanocarriers as drug delivery systems in Chagas disease
Quijia, C. R., Azevedo, C. S., Charneau, S. O., Santana, J. M., Chorilli, M., Carneiro, M. L. B., & Bastos, I. M. D. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s206109 · Cited by 41
Tan, K. F., In, L. L. A., & Kumar, P. V. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00202 · Cited by 42
Wang, J., Xie, Y., Wang, L., Tang, J., Li, J., Kocaefe, D., Kocaefe, Y. S., Zhang, Z., Li, Y., & Chen, C. (2014) · RSC Advances · doi:10.1039/c4ra13228a · Cited by 40
Translational nanorobotics breaking through biological membranes
Ressnerova, A., Heger, Z., & Pumera, M. (2025) · Chemical Society Reviews · doi:10.1039/d4cs00483c · Cited by 39
Silva, F., Zambre, A. P., Campello, M. P. C., Gano, L., Santos, I., Ferraria, A. M., Ferreira, M. J., Singh, A., Upendran, A., Paulo, A., et al. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00102 · Cited by 39
Elci, S. G., Tonga, G. Y., Yan, B., Kim, S. T., Kim, C. S., Jiang, Y. Y., Saha, K., Moyano, D. F., Marsico, A. L. M., Rotello, V. M., et al. (2017) · ACS Nano · doi:10.1021/acsnano.7b03711 · Cited by 39
Self-citationLiu, L., Ye, Q., Lu, M., Chen, S.-T., Tseng, H., Lo, Y.-C., & Ho, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-16293-6 · Cited by 39
Nanomedicine for the cardiac myocyte: Where are we?
Lozano, O., Torres‐Quintanilla, A., & García‐Rivas, G. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.018 · Cited by 40
Florczak, A., Deptuch, T., Lewandowska, A., Penderecka, K., Kramer, E., Marszałek, A., Mackiewicz, A. A., & Dams‐Kozlowska, H. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00734-y · Cited by 39
Razavi, Z. S., Razavi, F. S., & Alizadeh, S. S. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117357 · Cited by 39
A surface-adaptive nanocarrier to prolong circulation time and enhance cellular uptake
Cheng, T., Ma, R., Zhang, Y., Ding, Y., Liu, J., Ou, H., An, Y., Liu, J., & Shi, L. (2015) · Chemical Communications · doi:10.1039/c5cc05854f · Cited by 38
Asem, H., Zhao, Y. H., Ye, F., Barrefelt, Å., Abedi‐Valugerdi, M., El-Sayed, R., Serafi, I. E., Abu–Salah, K. M., Hamm, J., Muhammed, M. A., et al. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0239-0 · Cited by 38
pH-triggered cancer-targeting polymers: From extracellular accumulation to intracellular release
Khan, R. U., Shao, J., Liao, J., & Qian, L. (2023) · Nano Research · doi:10.1007/s12274-022-5252-z · Cited by 39
Kong, Y. W., & Dreaden, E. C. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.879988 · Cited by 37
Lim, E., Kim, B., Choi, Y., Ro, Y., Cho, E.-J., Lee, J. H., Ryu, S. H., Suh, J., Haam, S., & Huh, Y. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34678 · Cited by 37
Cell-derived membrane biomimetic nanocarriers for targeted therapy of pulmonary disease
Zheng, X., Zhang, T., Huang, T., Zhou, Y., & Gao, J. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121757 · Cited by 37
Covalent IR820-PEG-diamine nanoconjugates for theranostic applications in cancer
Fernandez-Fernandez, A., Manchanda, R., Carvajal, D. A., Lei, T., Srinivasan, S., & McGoron, A. J. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s69550 · Cited by 36
Site‐Specific Zwitterionic Polymer Conjugates of a Protein Have Long Plasma Circulation
Bhattacharjee, S., Liu, W., Wang, W., Weitzhandler, I., Li, X., Qi, Y., Liu, J., Pang, Y., Hunt, D. F., & Chilkoti, A. (2015) · ChemBioChem · doi:10.1002/cbic.201500439 · Cited by 36
Rajendrakumar, S. K., Chang, N.-C., Mohapatra, A., Uthaman, S., Lee, B.-I., Tsai, W., & Park, I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041189 · Cited by 36
Saraiva, S. M., Gutiérrez-Lovera, C., Martínez-Val, J., Lores, S., Bouzo, B. L., Díez‐Villares, S., Alijas, S., Pensado‐López, A., Vázquez-Ríos, A. J., Sanchez, L. E., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-87968-4 · Cited by 36
Zhao, X., Cui, H., Chen, W., Wang, Y., Cui, B., Sun, C., Meng, Z., & Liu, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098919 · Cited by 36
Vincent, M. P., Karabin, N. B., Allen, S. D., Bobbala, S. K. R., Frey, M. A., Yi, S., Yang, Y., & Scott, E. A. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100062 · Cited by 34
Passive vs. Active Targeting: An Update of the EPR Role in Drug Delivery to Tumors
Upponi, J. R., & Torchilin, V. P. (2014) · Advances in delivery science and technology · doi:10.1007/978-3-319-08084-0_1 · Cited by 34
Rezaei, G., Daghighi, S. M., Raoufi, M., Esfandyari‐Manesh, M., Rahimifard, M., Mobarakeh, V. I., Kamalzare, S., Ghahremani, M. H., Atyabi, F., Abdollahi, M. R., et al. (2019) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2019.08.060 · Cited by 34
Gold Polymer Nanomaterials: A Promising Approach for Enhanced Biomolecular Imaging
Kumar, P. P. P., & Mahajan, R. (2023) · Nanotheranostics · doi:10.7150/ntno.89087 · Cited by 33
Overcoming biological barriers to improve solid tumor immunotherapy
Ukidve, A., Cu, K., Kumbhojkar, N., Lahann, J., & Mitragotri, S. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00923-8 · Cited by 33
Peddada, L. Y., Garbuzenko, O. B., Devore, D. I., Minko, T., & Roth, C. M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.08.023 · Cited by 33
Tang, H., Yang, S., Ke, D.-M., Yang, Y.-F., Liu, J., Chen, X., Wang, H., & Liu, Y. (2017) · Toxicology Research · doi:10.1039/c7tx00137a · Cited by 33
Chemistry for oncotheranostic gold nanoparticles
Trouiller, A. J., Hebié, S., Bahhaj, F. E., Napporn, T. W., & Bertrand, P. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.05.024 · Cited by 32
Sulforaphane-conjugated selenium nanoparticles: towards a synergistic anticancer effect
Krug, P., Mielczarek, L., Wiktorska, K., Kaczyńska, K., Wojciechowski, P., Andrzejewski, K., Ofiara, K., Szterk, A., & Mazur, M. (2018) · Nanotechnology · doi:10.1088/1361-6528/aaf150 · Cited by 32
Nanotechnology in the diagnostic and therapy for Alzheimer's disease
Panghal, A., & Flora, S. J. S. (2024) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2024.130559 · Cited by 31
Yan, B., Jeong, Y., Mercante, L. A., Tonga, G. Y., Kim, C., Zhu, Z., Vachet, R. W., & Rotello, V. M. (2013) · Nanoscale · doi:10.1039/c3nr01384g · Cited by 31
Self-citationLiu, P., Boyle, A. J., Lu, Y., Adams, J., Chi, Y., Reilly, R. M., & Winnik, M. A. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b01066 · Cited by 30
Lynn, G. M., Laga, R., & Jewell, C. M. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.114427 · Cited by 31
Alexander, E., & Leong, K. W. (2025) · Frontiers in Nanotechnology · doi:10.3389/fnano.2025.1512622 · Cited by 29
Polymer-based nanoparticles for cancer theranostics: advances, challenges, and future perspectives
Shanahan, K., Coen, D., & Nafo, W. (2025) · Exploration of BioMat-X · doi:10.37349/ebmx.2025.101342 · Cited by 29
Metadata
- Authors
- Arvizo, R. R., Miranda, O. R., Moyano, D. F., Walden, C. A., Giri, K., Bhattacharya, R., Robertson, J. D., Rotello, V. M., Reid, J. M., & Mukherjee, P.
- Affiliations
- Mayo Clinic (US)
- University of Massachusetts Amherst (US)
- University of Missouri (US)
- Corresponding author
- Mukherjee, Priyabrata
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-09-13
- Volume
- 6
- Issue
- 9
- Pages
- e24374
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3172229
- OpenAlex
- W2053311966
- Cited by
- 403
- References
- 43
- Citations by year
- 2026: 11 · 2025: 25 · 2024: 25 · 2023: 27 · 2022: 27 · 2021: 36 · 2020: 37 · 2019: 41 · 2018: 23 · 2017: 34 · 2016: 30 · 2015: 24 · 2014: 21 · 2013: 27 · 2012: 11
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health (GM077173)
- National Cancer Institute (R01CA136494, CA135001, CA136494)
- National Institute of General Medical Sciences (GM-077173, R01GM077173)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Materials Chemistry › Nanoparticles: synthesis and applications
- Keywords
- engineered nanoparticles, surface charge, surface chemistry, pharmacokinetics, tumor uptake, tissue distribution, circulation time, zwitterionic nanoparticles, passive targeting, nanoparticle clearance, nude mice, intraperitoneal injection, intravenous injection
- MeSH terms
- Animals, Gold, Ligands, Male, Neoplasms, Surface Properties, Time Factors, Tissue Distribution, Nanotechnology, Cell Line, Tumor, Mice, Metal Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review